Skip to content

Medical-device intelligence

Meridian Bioscience Inc: FDA clearances and recalls

Research Meridian Bioscience Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

37 clearance records and 22 recall records in the covered releases, across 1 source company names and 25 product codes. Dated history runs from Dec 26, 2002 to Dec 5, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202502
November 202500
December 202501
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

59 matching records
Device / recordCompany in FDA recordSourceSource date
Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300Z-1019-2026 · OZNMeridian Bioscience IncRecallJan 5, 2026FDA classification date
Meridian Bioscience, alethia c. Difficile, Catalog Number 480050, Nucleic Acid Amplification Test AssayZ-0568-2026 · OMNMeridian Bioscience IncRecallNov 19, 2025FDA classification date
Meridian Bioscience, Group B Streptococcus, Catalog Number 480050, Nucleic Acid Amplification Test AssayZ-0569-2026 · NJRMeridian Bioscience IncRecallNov 19, 2025FDA classification date
RevogeneK243922 · OOIMeridian Bioscience, Inc.510(k)Mar 20, 2025FDA decision date
Para-Pak Clean Vial-For the collection, transportation, preservation, and examination of stool specimens containing intestinal parasites Catalog …Z-0519-2024 · FMHMeridian Bioscience IncRecallDec 8, 2023FDA classification date
Para-Pak Zn-PVA/10% Formalin-for the routine collection, transportation, preservation, and examination of stool specimens for intestinal parasite…Z-0520-2024 · IGGMeridian Bioscience IncRecallDec 8, 2023FDA classification date
Cardinal Health Clean Stool Transportation System-For the collection, transportation, preservation, and examination of stool specimens containing…Z-0521-2024 · FMHMeridian Bioscience IncRecallDec 8, 2023FDA classification date
Premier HpSA Flex (619096)K230901 · LYRMeridian Bioscience, Inc.510(k)Jul 3, 2023FDA decision date
Curian® Shiga ToxinK222829 · GMZMeridian Bioscience, Inc.510(k)Apr 17, 2023FDA decision date
RevogeneK222779 · OOIMeridian Bioscience, Inc.510(k)Jan 26, 2023FDA decision date
Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700Z-1008-2023 · QJRMeridian Bioscience IncRecallJan 20, 2023FDA classification date
Revogene, Catalog no. 610210. IVD test instrumentZ-1479-2022 · OOIMeridian Bioscience IncRecallJul 28, 2022FDA record creation date
RevogeneK220480 · OOIMeridian Bioscience, Inc.510(k)Jul 11, 2022FDA decision date
Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clinical laboratories. Meridian branded Revogene: Catalog Number 610…Z-0836-2022 · OOIMeridian Bioscience IncRecallMar 30, 2022FDA record creation date
Curian CampyK210976 · LQPMeridian Bioscience, Inc.510(k)Dec 23, 2021FDA decision date
Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on …Z-1540-2021 · QJRMeridian Bioscience IncRecallMay 7, 2021FDA record creation date
Revogene RNA Software Upgrade Kit Revogene RNA Software Upgrade USBs Catalog Number: 610240 IVD used to install the Revogene System Software ver…Z-1541-2021 · QJRMeridian Bioscience IncRecallMay 7, 2021FDA record creation date
The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum - Product Usage: intended to aid in the diagnosis of recent M…Z-1299-2021 · LJZMeridian Bioscience IncRecallMar 24, 2021FDA record creation date
Curian HpSA, Curian AnalyzerK192817 · LYRMeridian Bioscience, Inc.510(k)Mar 13, 2020FDA decision date
PREMIER Cryptococcal Antigen, Catalog Number 602096 Product Usage: The PREMIER Cryptococcal Antigen enzyme immunoassay (EIA) is a screening or …Z-0732-2019 · MDUMeridian Bioscience IncRecallJan 14, 2019FDA record creation date
PREMIER Platinum HpSA PLUSK182559 · LYRMeridian Bioscience, Inc.510(k)Nov 5, 2018FDA decision date
TRU LegionellaK163273 · MJHMeridian Bioscience, Inc.510(k)Feb 21, 2017FDA decision date
PREMIER EHEC and PREMIER EHEC Bulk.Z-1033-2017 · GNAMeridian Bioscience IncRecallJan 17, 2017FDA classification date
illumigene Mycoplasma Direct DNA Amplification Assay, illumigene Mycoplasma Direct External Controls, illumipro-10K160829 · OZXMeridian Bioscience, Inc.510(k)Jun 13, 2016FDA decision date
ImmunoCard STAT! HpSAK153661 · LYRMeridian Bioscience, Inc.510(k)Mar 14, 2016FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗